IDiyas

For the Inventor, By the Inventor

Brookline, MA, United States of America

Zhigang Weng

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Cambridge, MA (US) (2001 - 2002)
  • Los Angeles, CA (US) (2001 - 2003)
  • Brookline, MA (US) (2003 - 2023)

Company Filing History:

goldMedal7 out of 40 
 
Aveo Pharmaceuticals, Inc.
 patents
silverMedal6 out of 15,458 
 
University of California
 patents

Years Active: 2001-2025

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):
1. 12258391 - Anti-GDF-15 antibodies (2025-03-25),
2. 11725047 - Anti-GDF-15 antibodies (2023-08-15),
3. 10597444 - Anti-GDF15 antibodies (2020-03-24),
4. 9725505 - Methods of treatment using anti-GDF15 antibodies (2017-08-08),
5. 9175076 - Anti-GDF15 antibodies (2015-11-03),
6. 8481688 - Anti-FGFR2 antibodies (2013-07-09),
7. 8187601 - Fibroblast growth factor receptor 3 (FGFR3) binding proteins (2012-05-29),
8. 6709830 - Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation (2004-03-23),
9. 6569995 - Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells (2003-05-27),
10. 6514696 - Transcriptionally regulated G protein-coupled receptor G2A (2003-02-04),
11. 6383760 - Transcriptionally regulated G protein-coupled receptor (2002-05-07),
12. 6214562 - Transcriptionally regualted G protein-coupled receptor (2001-04-10),
13. 6207412 - Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells (2001-03-27),

Title: Zhigang Weng: Pioneering Innovator in the World of Science

Introduction:

Inventor Zhigang Weng, based in Brookline, MA (US), is a distinguished figure in the world of inventors, renowned for his relentless pursuit of innovation. With a staggering 12 patents to his name, Weng's passion for creating solutions to complex problems sets him apart as a visionary in the field.

Latest Patents:

Among his latest patents are the groundbreaking "Anti-GDF-15 antibodies," which entail monoclonal antibodies that bind and inhibit the activity of human GDF15. These innovative antibodies have the potential to revolutionize the treatment of body weight loss, especially cachexia, associated with the over-expression of human GDF15.

Career Highlights:

Weng has left an indelible mark on the scientific community through his work with notable companies such as Aveo Pharmaceuticals, Inc., and the University of California. His contributions have not only advanced the field of medicine but have also opened new avenues for research and development in the realm of healthcare.

Collaborations:

Throughout his career, Weng has collaborated with esteemed colleagues such as William M Winston, Jr. and Solly Weiler, who have played pivotal roles in shaping his innovative endeavors. Together, they have synergized their expertise to drive forward groundbreaking inventions that have the potential to transform lives.

Conclusion:

Inventor Zhigang Weng's unwavering dedication to innovation and his fervent commitment to tackling challenging issues make him a standout figure in the world of science. His remarkable journey serves as an inspiration to future generations of innovators, urging them to push the boundaries of what is deemed possible and to strive for excellence in all their endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…